Trials / Completed
CompletedNCT00968422
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ABT-384 in elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-384 | 3 escalating doses will be administered daily for 21 days |
| DRUG | Matching placebo to ABT-384 | Doses will be administered daily for 21 days |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-01-01
- First posted
- 2009-08-31
- Last updated
- 2010-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00968422. Inclusion in this directory is not an endorsement.